Nicolas Theys

Nicolas Theys

Company: NOVADIP Biosciences

Job title: Chief Technology Officer

Seminars:

Strategising the Transition from Autologous to Allogeneic Cell Therapy Platforms 11:30 am

• Evaluating development and manufacturing considerations for converting autologous therapies • Discussing strategies to balance implementing allogeneic products while continuing autologous programs • Comparing regulatory requirements between autologous and allogeneic platformsRead more

day: Day Two

Venue details

Hilton London Olympia 

380 Kensington High St,

London

W14 8NL

Location

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.